TrialClinical lung cancer2011

Randomized phase II trial of concurrent versus sequential bortezomib plus docetaxel in advanced non-small-cell lung cancer: a California cancer consortium trial.

Primo N Lara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.